A tumor-targeted nanodelivery system to improve early MRI detection of cancer

Molecular Imaging

Volumn 5, Issue 1, 2006, Pages 41-52

  Pirollo, Kathleen F ^a   Dagata, John ^b   Wang, Paul ^c   Freedman, Matthew ^a   Vladar, Andras ^b   Fricke, Stanley ^a   Ileva, Lilia ^a   Zhou, Qi ^a   Chang, Esther H ^a,d  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^c HOWARD UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Early detection; Magnevist ; MRI; Nanocomplex; Tumor targering

Indexed keywords

EARLY DETECTION; MAGNEVIST®; NANOCOMPLEX; TUMOR TARGERING;

DISEASES; GENES; GROWTH KINETICS; PHYSIOLOGICAL MODELS; TUMORS; VISUALIZATION;

MAGNETIC RESONANCE IMAGING;

DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; IMMUNOGLOBULIN FC FRAGMENT; LIPOSOME; TRANSFERRIN RECEPTOR;

ANIMAL; ARTICLE; CELL STRAIN K 562; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG SCREENING; EARLY DIAGNOSIS; GENE THERAPY; GENETICS; HUMAN; IMMUNOLOGY; LIVER TUMOR; METASTASIS; METHODOLOGY; MOUSE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PANCREAS TUMOR; SCANNING ELECTRON MICROSCOPY; SCANNING PROBE MICROSCOPY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; EARLY DIAGNOSIS; GADOLINIUM DTPA; GENE THERAPY; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; K562 CELLS; LIPOSOMES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, SCANNING PROBE; NANOTECHNOLOGY; PANCREATIC NEOPLASMS; RECEPTORS, TRANSFERRIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33646257756     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2006.00005     Document Type: Article

References (33)

1. Gillies RJ, Bhujwalla ZM, Evelhoch J, Garwood M, Neeman M, Robinson SP, Sotak CH, Van Der SB (2000). Applications of magnetic resonance in model systems: Tumor biology and physiology. Neoplasia. 2:139-151.
2. Degani H, Chetrit-Dadiani M, Bogin L, Furman-Haran E (2003). Magnetic resonance imaging of tumor vasculature. Thromb Haemost. 89:25-33.
3. Xu L, Pirollo K, Tang W, Rait A, Chang EH (1999). Transferrinliposome- mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther. 10:2941-2952.
4. Xu L, Pirollo K, Chang EH, Murray A (1999). Systemic p53 gene therapy in combination with radiation results in human tumor regression. Tumor Targeting 4:92-104.
5. Xu L, Tang WH, Huang CC, Alexander W, Xiang LM, Pirollo KF, Rait A, Chang EH (2001). Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med. 7:723-734.
6. Xu L, Huang C-C, Huang W-Q, Tang W-H, Rait A, Yin Y, Cruz I, Xiang L-M, Pirollo K, Chang EH (2002). Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunolipo-somes. Mol Cancer Ther. 1:337-346.
7. Rait A, Pirollo KF, Xiang LM, Ulick D, Chang EH (2002). Tumortargeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels. Mol Med. 8:476-487.
8. Rait A, Pirollo KF, Ulick D, Cullen K, Chang EH (2003). HER-2-targeted antisense oligonucleotides result in sensitization of head and neck cancer cells to chemotherapeutic agents. Ann NY Acad Sci. 1002:1-12.
9. Cristiano RJ, Curiel DT (1996). Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther. 3:49-57.
10. Cheng PW (1996). Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther. 7:275-282.
11. Keer HN, Kozlowski JM, Tsai YC, Lee C, McEwan RN, Grayhack JT (1990). Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol. 143: 381-385.
12. Rossi MC, Zetter BR (1992). Selective stimulation of prostatic carcinoma cell proliferation by transferrin. Proc Natl Acad Sci USA. 89:6197-6201.
13. Elliott RL, Elliott MC, Wang F, Head JF (1993). Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study. Ann NY Acad Sci. 698:159-166.
14. Thorstensen K, Romslo I (1993). The transferrin receptor: Its diagnostic value and its potential as therapeutic target. Scand J Clin Lab Invest Suppl. 215:113-120.
15. Miyamoto T, Tanaka N, Eishi Y, Amagasa T (1994). Transferrin receptor in oral tumors. Int J Oral Maxillofac Surg. 23:430-433.
16. Ponka P, Lok CN (1999). The transferrin receptor: Role in health and disease. Int J Biochem Cell Biol. 31:1111-1137.
17. Haynes BF, Hemler M, Cotner T, Mann DL, Eisenbarth GS, Strominger JL, Fauci AS (1981). Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J Immunol. 127:347-351.
18. Batra JK, Fitzgerald DJ, Chaudhary VK, Pastan 1 (1991). Singlechain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: Anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv). Mol Cell Biol. 11:2200-2205.
19. Jain RK, Baxter LT (1988). Mechanisms of heterogenous distribution of monoclonal antibodies and other macro-molecules in tumors: Significance of elevated interstitial pressure. Cancer Res. 48:7022-7032.
20. Wolfert MA, Schacht EH, Toncheva V, Ulbrich K, Nazarova O, Seymour LW (1996). Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block copolymers. Hum Gene Ther. 7:2123-2133.
21. Dunlap DD, Maggi A, Soria MR, Monaco L (1997). Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res. 25:3095-3101.
22. Kawaura C, Noguchi A, Furuno T, Nakanishi M (1998). Atomic force microscopy for studying gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. FEBS Lett. 421:69-72.
23. [23[ Choi YH, Liu F, Choi JS, Kim SW, Park JS (1999). Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysinc and its complex with plasmid DNA. Hum Gene Ther 10:2657-2665.
24. Diebel CE, Proksch R, Green CR, Neilson P, Walker MM (2000). Magnetite defines a vertebrate magnetoreceptor. Nature. 406: 299-302.
25. Rasa M, Kuipers BWM, Philipse AP (2002). Atomic force microscopy and magnetic force microscopy study of model colloids. J Colloid Interface Sci. 250:303-315.
26. Yu W, Pirollo KF, Yu B, Rait A, Xiang L, Huang W, Zhou Q, Ertem G, Chang EH (2004). Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide. Nucleic Acids Res. 5.
27. Alisauskus R, Wong GY, Gold DV (1995). Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer. Cancer Res. 55:5743s-5748s.
28. Foo JJ, Chan V, Liu KK (2003). Contact deformation of liposome in the presence of osmosis. Ann Biomed Eng. 31:1279-1286.
29. Xu L, Frederick P, Pirollo K, Tang W, Rait A, Xiang L, Huang W-Q, Chang EH (2002). Self-assembly of a virus-mimicking nano-structure system for efficient tumor-targeted gene delivery. Hum Gene Ther. 13:469-481.
30. Freedman M, Sarcone A, Pirollo KF, Lin C, Chang EH (2001). Ultrasound images of implanted tumors in nude mice using Sono-CT® correlated with MRI appearance. SPIE Medical Imaging: Physiology and Function from Multidimensional Images. 4321:163-167.
31. Wisner ER, Weichert JP, Longino MA, Counsell RE, Weisbrode SE (2002). A surface-modified chylomicron remnant-like emulsion for percutaneous computed tomography lymphography: Synthesis and preliminary imaging findings. Invest Radial. 37: 232-239.
32. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA (2003). Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin- targeted nanoparticles. Circulation. 108:2270-2274.
33. Morawski AM, Winter PM, Crowder KC, Caruthers SD, Fuhrhop RW, Scott MJ, Robertson JD, Abendschein DR, Lanza GM, Wickline SA (2004). Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med. 51:480-486.